- Exchange: Frankfurt
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Galena Biopharma Inc+ Add to Watchlist
RXK:GR1.329 EUR 0.126 10.47%
As of 11:30:58 ET on 04/17/2015.
Company Profile for Galena Biopharma Inc (RXK)
Galena Biopharma, Inc. is a biopharmaceuticals company that develops late-stage oncology drugs. The Company develops therapies that activate cells in the immune system to seek out and eliminate tumor cells without harming healthy tissue.
Galena Biopharma Inc
Key Executives for Galena Biopharma Inc (RXK)
|Mark W SchwartzPresident/CEO||Ryan M DunlapVP/CFO/Secretary|